Vertigo
86 results
1 - 86
Betahistine for symptoms of vertigo: Cochrane systematic review- The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo: Cochrane systematic review
- Modifications of the Epley (canalith repositioning) manoeuvre for posterior canal benign paroxysmal positional vertigo (BPPV)
- Intratympanic corticosteroids for Ménière’s disease
- Positive pressure therapy for Ménière’s disease
- Intratympanic gentamicin for Ménière's disease or syndrome
- Non‐pharmacological interventions for prophylaxis of vestibular migraine
- Intratympanic gentamicin for Ménière’s disease
- Systemic pharmacological interventions for Ménière’s disease
- Intratympanic steroids for Ménière's disease or syndrome: Cochrane systematic review
- Surgical interventions for Ménière’s disease
- Pharmacological interventions for prophylaxis of vestibular migraine
- Positive pressure therapy for Ménière's disease or syndrome
- Pharmacological interventions for acute attacks of vestibular migraine
- Betahistine for Ménière's disease or syndrome
- Lifestyle and dietary interventions for Ménière’s disease
- Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
- Surgery for Ménière's disease
- Diuretics for Ménière's disease or syndrome
- Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis): Cochrane systematic review
- Pharmacological agents for the prevention of vestibular migraine
- Intratympanic corticosteroids for sudden sensorineural hearing loss
- Phosphodiesterase III inhibitors for heart failure
- Aural toilet (ear cleaning) for chronic suppurative otitis media
- Antiepileptic drugs for preventing seizures in people with brain tumors
- Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
- Steroids for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Antivirals for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Clobazam add‐on therapy for drug‐resistant epilepsy
- Pharmacologic interventions for treating phantom limb pain
- Sodium channel blockers for neuroprotection in multiple sclerosis
- Angioplasty versus stenting for subclavian artery stenosis
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction: Cochrane systematic review
- Cannabinoids for fibromyalgia
- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Tricyclic drugs for depression in children and adolescents
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- Botulinum toxin for subacute/chronic neck pain: Cochrane systematic review
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
- Baclofen for alcohol use disorder
- Lacosamide add‐on therapy for focal epilepsy
- Exercise for acutely hospitalised older medical patients
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Oral sumatriptan for acute migraine: Cochrane systematic review
- Meditation for the primary and secondary prevention of cardiovascular disease
- Chloral hydrate as a sedating agent for neurodiagnostic procedures in children